XML 33 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements

Fair value of an asset or liability is the price that would be received to sell that asset or paid to transfer that liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  ASC Topic 820 establishes a fair value hierarchy for valuation inputs that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the Company has the ability to access as of the measurement date.

Level 2: Significant other observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, and other inputs that are observable or can be corroborated by observable market data.

Level 3: Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The Company bases fair value of assets and liabilities on quoted market prices, prices for similar assets or liabilities, quoted prices in markets that are not active, and other inputs that are observable or can be corroborated by observable market data.  If such information is not available, fair value is based upon internally developed models that primarily use, as inputs, observable market-based parameters.  Valuation adjustments may be made to ensure that financial instruments are recorded at fair value.  These adjustments may include amounts to reflect counterparty credit quality and the Company’s creditworthiness, among other things, as well as unobservable parameters.  Any such valuation adjustments are applied consistently over time.  The Company’s valuation methodologies may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values.  While management believes the Company’s valuation methodologies are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.  Furthermore, the reported fair value amounts have not been comprehensively revalued since the presentation dates, and therefore, estimates of fair value after the balance sheet date may differ significantly from the amount presented herein.  A more detailed description of the valuation methodologies used for assets and liabilities measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below.

Financial Assets and Liabilities

The Company used the following methods and significant assumptions to estimate fair value for financial assets and liabilities measured on a recurring basis.

Securities Available for Sale.  Securities available for sale are reported at fair value utilizing Level 1, Level 2, and Level 3 inputs.  The fair value of securities available for sale is determined by utilizing a market approach by obtaining quoted prices on nationally recognized securities exchanges (other than forced or distressed transactions) that occur in sufficient volume or matrix pricing, which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities.  If such measurements are unavailable, the security is classified as Level 3.  Significant judgment is required to make this determination.

The Company utilizes a third party pricing service provider to value its Level 1 and Level 2 investment securities.  Annually, the Company obtains an independent auditor’s report from its third party pricing service provider regarding its controls over investment securities. On a quarterly basis, the Company reprices its debt securities with a third party that is independent of the primary pricing service provider to verify the reasonableness of the fair values.

Derivatives. Derivatives are reported at fair value utilizing Level 2 inputs.  The Company utilizes a market approach by obtaining dealer quotations to value its customer interest rate swaps.  The Company’s derivatives are included within Other Assets and Other Liabilities in the accompanying consolidated balance sheets. Derivative assets are typically secured through securities with financial counterparties or cross collateralization with a borrowing customer. Derivative liabilities are typically secured through the Company pledging securities to financial counterparties or, in the case of a borrowing customer, by the right of setoff. The Company considers factors such as the likelihood of default by itself and its counterparties, right of setoff, and remaining maturities in determining the appropriate fair value adjustments. All derivative counterparties approved by the Company's Asset and Liability Committee ("ALCO") are regularly reviewed, and appropriate business action is taken to adjust the exposure to certain counterparties, if necessary. Counterparty exposure is evaluated by netting positions that are subject to master netting agreements, as well as considering the amount of marketable collateral securing the position. This approach used to estimate impacted exposures to counterparties is also used by the Company to estimate its own credit risk in derivative liability positions. To date, no material losses have been incurred due to a counterparty's inability to pay any undercollateralized position. There was no significant change in the value of derivative assets and liabilities attributed to credit risk that would have resulted in a derivative credit risk valuation adjustment at March 31, 2019.

The Company may be required, from time to time, to measure certain financial assets and financial liabilities at fair value on a nonrecurring basis.  Financial assets measured at fair value on a nonrecurring basis include impaired loans reported at the fair value of the underlying collateral if repayment is expected solely from the collateral.  Collateral values are estimated using Level 2 inputs based on observable market data for real estate collateral or Level 3 inputs for non-real estate collateral.  The following table presents assets and liabilities measured at fair value (in thousands):
 
Total
Level 1
Level 2
Level 3
Total Gains (Losses)
March 31, 2019
 
 
 
 
 
Recurring fair value measurements
 
 
 
 
 
Financial Assets
 
 
 
 
 
U.S. Government agencies
$
2,300

$

$
2,300

$

 
Obligations of states and political subdivisions
125,640


125,640


 
Mortgage-backed securities:
 

 
 
 
 
U.S. Government agencies
588,698


588,698


 
Private label
12,115


12,115


 
Trust preferred securities
4,238


3,977

261

 
Corporate securities
16,879


16,879


 
Marketable equity securities
10,388

6,050

4,338


 
Certificates of deposit held for investment
3,735

 
3,735

 
 
Investment funds
1,476

1,476



 
Derivative assets
13,582


13,582


 
Financial Liabilities
 

 

 

 

 
Derivative liabilities
13,482


13,482


 
 
 
 
 
 
 
Nonrecurring fair value measurements
 

 

 

 

 
Financial Assets
 
 
 
 
 
Impaired loans
$
9,468

$

$

$
9,468

$
(74
)
Non-Financial Assets
 
 
 
 
 
     Other real estate owned
3,186



3,186

(213
)
 
 
 
 
 
 
December 31, 2018
 

 

 

 

 

Recurring fair value measurements
 

 

 

 

 

Financial Assets
 

 

 

 

 

U.S. Government agencies
$
5,733

$

$
5,733

$

 

Obligations of states and political subdivisions
128,070


128,070


 

Mortgage-backed securities:
 

 
 
 
 

U.S. Government agencies
550,758


550,758


 

Private label
12,043


12,043


 

Trust preferred securities
4,799


4,538

261

 

Corporate securities
16,658


16,658


 

Marketable equity securities
10,313

5,907

4,406


 

Certificates of deposit held for investment
3,735

 
3,735

 
 
Investment funds
1,458

1,458



 

Derivative assets
17,100


17,100


 

Financial Liabilities
 

 
 
 
 

Derivative liabilities
16,905


16,905


 

 
 
 
 
 
 
Nonrecurring fair value measurements
 

 

 

 

 

Financial Assets
 
 
 
 
 
Impaired loans
$
10,078

$

$

$
10,078

$
(428
)
Non-Financial Assets
 
 
 
 
 
Other real estate owned
4,608



4,608

(838
)
Other assets
600



600

(492
)

The table below presents a reconcilement of the Company's financial assets and liabilities measured at fair value on a nonrecurring basis using significant unobservable inputs (Level 3), which solely relates to impaired loans that were remeasured and reported at fair value through a specific valuation allowance allocation of the allowance for loan losses based upon the fair value of the underlying collateral (in thousands).  The fair value of impaired loans is estimated using one of several methods, including collateral value, liquidation value and discounted cash flows.  The significant unobservable inputs used in the fair value measurement of collateral for collateral-dependent impaired loans primarily relate to discounts applied to the customers’ reported amount of collateral.  The amount of collateral discount depends upon the marketability of the underlying collateral.  During the three months ended March 31, 2019 and 2018, collateral discounts ranged from 20% to 30%. During the three months ended March 31, 2019 and 2018, the Company had no Level 2 financial assets and liabilities that were measured on a nonrecurring basis.

 
Three months ended March 31,
2019
2018
 
 
 
Beginning balance
$
10,078

$
9,020

 
 
 
Loans classified as impaired during the period


Specific valuation allowance allocations


Loans classified as impaired during the period, net of specific valuation allowances


 
 
 
Reduction in (additional) specific valuation allowance allocations
74

(474
)
Paydowns, payoffs, other activity
(684
)
888

Ending balance
$
9,468

$
9,434



Non-Financial Assets and Liabilities

The Company has no non-financial assets or liabilities measured at fair value on a recurring basis.  Certain non-financial assets measured at fair value on a non-recurring basis include other real estate owned (“OREO”), which is measured at the lower of cost or fair value, and goodwill and other intangible assets, which are measured at fair value for impairment assessments. The table below presents OREO that was remeasured and reported at fair value based on significant unobservable inputs (Level 3) (in thousands):

 
Three months ended March 31,
 
2019
2018
 
 
 
Beginning balance
$
4,608

$
3,585

OREO remeasured at initial recognition:
 
 
   Carrying value of foreclosed assets prior to remeasurement
706

1,218

   Charge-offs recognized in the allowance for loan losses
(401
)
(353
)
     Fair value
305

865

OREO remeasured subsequent to initial recognition:
 
 
   Carrying value of foreclosed assets prior to remeasurement
1,300

1,362

   Fair value
1,087

1,149

     Write-downs included in other non-interest expense
(213
)
(213
)
 
 
 
Disposed
(1,514
)
(325
)
Ending balance
$
3,186

$
3,912



ASC Topic 825 “Financial Instruments,” as amended, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet, for which it is practicable to estimate that value.  In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques.  Those techniques are significantly affected by the assumptions used, including discount rates and estimate of future cash flows.  In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in immediate settlement of the instrument.  ASC Topic 825 excludes certain financial instruments and all nonfinancial instruments from its disclosure requirements.  Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The following methods and assumptions were used in estimating fair value for financial instruments:

Cash and cash equivalents: Due to their short-term nature, the carrying amounts reported in the consolidated balance sheets approximate fair value.

Securities:  The fair value of securities, both available-for-sale and held-to-maturity, are generally based on quoted market prices or matrix pricing, which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted securities.

Other securities: The Company's other securities consist of marketable equity securities and non-marketable equity securities. The fair value of marketable equity securities is generally based on quoted market prices. The fair value of non-marketable equity securities, which consist of FRB and FHLB stock, is not practicable to determine due to restrictions placed on its transferability.

Net loans:  The fair value of the loan portfolio is estimated by discounting the expected future cash flows using the current interest rates at which similar loans would be made to borrowers for the same remaining maturities, the credit risk associated with such loans and other market factors, including liquidity. Loans were first segregated by type such as commercial, real estate and consumer, and were then further segmented into fixed, adjustable and variable rate categories. Expected future cash flows were projected based on contractual cash flows, adjusted for estimated prepayments.

Accrued interest receivable: The carrying amount of accrued interest receivable approximates fair value.

Deposits:  The fair values of demand deposits (i.e., interest and noninterest-bearing deposits, regular savings and other money market demand accounts) are, by definition, equal to their carrying values. The fair values of time deposits were estimated using discounted cash flow analyses. The discount rates used were based on rates currently offered for deposits with similar remaining maturities. The fair values of the time deposit liabilities do not take into consideration the value of the Company’s long-term relationships with depositors, which may have significant value.

Short-term debt: Securities sold under agreements to repurchase and Federal Home Loan Bank advances represent borrowings with original maturities of less than 90 days. The carrying amount of borrowings under purchase agreements approximate their fair value.

Long-term debt: The fair value of long-term borrowings is estimated using discounted cash flow analyses based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements and market conditions of similar debt instruments.

Commitments and letters of credit: The fair values of commitments are estimated based on fees currently charged to enter into similar agreements, taking into consideration the remaining terms of the agreements and the counterparties’ credit standing.  The fair value of letters of credit is based on fees currently charged for similar agreements or on the estimated cost to terminate them or otherwise settle the obligations with the counterparties at the reporting date.  The amounts of fees currently charged on commitments and letters of credit are deemed insignificant, and therefore, the estimated fair values and carrying values have not been reflected in the table below.

The following table represents the estimates of fair value of financial instruments (in thousands). This table excludes financial instruments for which the carrying amount approximates fair value. For short-term financial assets such as cash and cash equivalents, the carrying amount is a reasonable estimate of fair value due to the relatively short time between the origination of the instrument and its expected realization. For financial liabilities such as noninterest-bearing demand, interest-bearing demand and savings deposits, the carrying amount is a reasonable estimate of fair value due to these products having no stated maturity.
 
Carrying Amount
Fair Value
Level 1
Level 2
Level 3
March 31, 2019
 
 
 
 
 
Assets:
   Cash and cash equivalents
$
143,850

$
143,850

$
143,850

$

$

   Securities available-for-sale
755,081

755,081

1,476

753,344

261

   Securities held-to-maturity
55,326

56,085


56,085


   Other securities
26,182

26,182

6,050

20,132


   Net loans
3,544,676

3,513,838



3,513,838

   Accrued interest receivable
13,657

13,657

13,657



   Derivative assets
13,582

13,582


13,582


 
 
 
 
 
 
Liabilities:
 
 
 
 
 
   Deposits
4,043,007

4,057,776

2,661,094

1,396,682


   Short-term debt
194,683

194,683


194,683


   Long-term debt
4,053

4,115


4,115


   Derivative liabilities
13,482

13,482


13,482


 
 
 
 
 
 
December 31, 2018
 

 

 

 

 

Assets:
 

 

 

 

 

   Cash and cash equivalents
122,991

122,991

122,991



   Securities available-for-sale
723,254

723,254

1,458

721,535

261

   Securities held-to-maturity
60,827

60,706


60,706


   Other securities
28,810

28,810

5,907

22,903


   Net loans
3,571,642

3,516,557



3,516,557

   Accrued interest receivable
12,424

12,424

12,424



   Derivative assets
17,100

17,100


17,100


 
 
 
 
 
 
Liabilities:
 
 
 
 
 
   Deposits
3,975,559

3,985,534

2,622,905

1,362,629


   Short-term debt
261,911

261,911


261,911


   Long-term debt
4,053

4,115


4,115


   Derivative liabilities
16,905

16,905


16,905